Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis

✍ Scribed by Elenir B. C. Avritscher; Scott B. Cantor; Ya-Chen T. Shih; Carmelita P. Escalante; Edgardo Rivera; Linda S. Elting

• Publisher: Springer-Verlag
• Year: 2004
• Tongue: English
• Weight: 154 KB
• Volume: 12
• Category: Article
• ISSN: 0941-4355
• DOI: 10.1007/s00520-004-0597-2